Patent ID: 8840938

Claim:
A bioavailability enhancing composition comprising an effective amount of a Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) agonist, wherein the TRPV1 agonist comprises Zingiber officinale, Piper nigrum , and Zanthoxylum piperitum with a combined Scoville Heat Unit (SHU) milligram (mg) dose in the range of 280,000 to 400,000 SHU mg, wherein SHU mg dose is calculated as the SHU of the TRPV1 agonist multiplied by milligrams of the TRPV1 agonist, wherein the Zingiber officinale is in the range of 20 to 30% by weight of the composition, the Piper nigrum is in the range of 2 to 6% by weight of the composition, and the Zanthoxylum piperitum is in the range of 25 to 35% by weight of the composition, and wherein oral administration of the composition increases nutrient bioavailability in a subject.